Chicken | Mouse | Marmoset | Human | Canonical signaling pathways |
---|---|---|---|---|
● | ● | 4-hydroxyproline degradation I | ||
● | ● | ● | Actin cytoskeleton signaling | |
● | ● | ● | Aldosterone signaling in epithelial cells | |
● | ● | Amyloid processing | ||
● | ● | ● | Amyotrophic lateral sclerosis signaling | |
● | ● | ● | Androgen receptor signaling | |
● | ● | Antiproliferative role of somatostatin receptor 2 signaling | ||
● | ● | ● | ● | Calcium signaling |
● | ● | Choline biosynthesis III | ||
● | ● | Chondroitin sulfate biosynthesis | ||
● | ● | ● | ● | Circadian rhythm signaling |
● | ● | ● | Clathrin-mediated endocytosis signaling | |
● | ● | ● | CREB signaling in neurons | |
● | ● | ● | ● | CXCR4 signaling |
● | ● | Diphthamide biosynthesis | ||
● | ● | Dopamine receptor signaling | ||
● | ● | ● | ● | Dopamine-DARPP32 feedback signaling |
● | ● | ● | EIF2 signaling | |
● | ● | ● | eNOS signaling | |
● | ● | ● | Ephrin B signaling | |
● | ● | ● | ● | Ephrin receptor signaling |
● | ● | ● | ● | Epithelial adherens junction signaling |
● | ● | ERK/MAPK signaling | ||
● | ● | ● | ● | Estrogen receptor signaling |
● | ● | ● | GABA receptor signaling | |
● | ● | ● | Gap junction signaling | |
● | ● | ● | ● | Glucocorticoid receptor signaling |
● | ● | ● | ● | Glutamate degradation/Glutamate receptor signaling |
● | ● | ● | Glutathione biosynthesis | |
● | ● | ● | Glutathione redox reactions I | |
● | ● | ● | Glutathione-mediated detoxification | |
● | ● | Glycoaminoglycan-protein linkage region biosynthesis | ||
● | ● | ● | Gαq signaling | |
● | ● | HIPPO signaling | ||
● | ● | ● | HMGB1 signaling | |
● | ● | ● | ● | Huntington’s disease signaling |
● | ● | ● | IGF-1 signaling | |
● | ● | ● | ILK signaling | |
● | ● | ● | Insulin receptor signaling | |
● | ● | ● | Integrin signaling | |
● | ● | ● | L-cysteine degradation I | |
● | ● | ● | ● | L-cysteine degradation III |
● | ● | Mismatch repair in eukaryotes | ||
● | ● | ● | mTOR signaling | |
● | ● | NF-κB signaling | ||
● | ● | ● | ● | nNOS signaling |
● | ● | ● | NRF2-mediated oxidative stress response | |
● | ● | ● | Oncostatin M signaling | |
● | ● | ● | Phospholipase C signaling | |
● | ● | ● | Phototransduction pathway | |
● | ● | ● | ● | PI3K/AKT signaling |
● | ● | ● | PPAR signaling | |
● | ● | ● | ● | PPARα/RXRα activation |
● | ● | ● | Production of nitric oxide and reactive oxygen species | |
● | ● | ● | ● | Protein kinase A signaling |
● | ● | ● | ● | Protein ubiquitination pathway |
● | ● | ● | PTEN signaling | |
● | ● | Purine nucleotides de novo biosynthesis II | ||
● | ● | ● | Purine nucleotides degradation II (aerobic) | |
● | ● | RAN signaling | ||
● | ● | ● | RAR activation | |
● | ● | ● | Regulation of eIF4 and p70S6K signaling | |
● | ● | ● | Regulation of the epithelial-mesenchymal transition pathway | |
● | ● | ● | Relaxin signaling | |
● | ● | ● | ● | RhoGDI signaling |
● | ● | Semaphorin signaling in neurons | ||
● | ● | ● | ● | Signaling by Rho family GTPases |
● | ● | Sumoylation pathway | ||
● | ● | Synaptic long-term depression | ||
● | ● | ● | ● | Synaptic long-term potentiation |
● | ● | ● | TGF-β signaling | |
● | ● | Tight junction signaling | ||
● | ● | ● | tRNA splicing | |
● | ● | ● | Wnt/Ca + pathway | |
● | ● | Xenobiotic metabolism signaling | ||
● | ● | ● | α-adrenergic signaling | |
● | ● | ● | β-adrenergic signaling |